{"schema_version":"secwatch.filing_event.v1","accession":"0000885590-21-000047","form_type":"8-K","ticker":"BHC","cik":"0000885590","company_name":"Bausch Health Companies Inc.","filed_at":"2021-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:04:21.076922+00:00","generated_at":"2026-06-29T00:33:09.154593+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Bausch Health names Seana Carson as General Counsel effective Bausch + Lomb IPO closing","bullets":["Christina Ackermann will become General Counsel of Bausch + Lomb upon IPO closing.","Joseph Gordon transfers to Bausch + Lomb to lead global consumer, vision care, surgical and EMEA pharma.","Seana Carson appointed General Counsel of Bausch Health, effective IPO closing.","Seana Carson base salary CA$665,000; cash incentive 60% of base; US$250,000 RSU grant.","Changes part of previously announced separation of Bausch + Lomb via IPO."],"urls":{"canonical":"https://secwatch.observer/filing/0000885590-21-000047","json":"https://secwatch.observer/filing/0000885590-21-000047.json","markdown":"https://secwatch.observer/filing/0000885590-21-000047.md","text":"https://secwatch.observer/filing/0000885590-21-000047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885590/000088559021000047/0000885590-21-000047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885590/000088559021000047/bhc-20210923.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T00:33:09.154593+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0c782bbad7","claim":"Seana Carson was appointed as General Counsel at Bausch Health Companies Inc..","evidence_excerpt":"In connection with Christina Ackermann’s Bausch + Lomb appointment, Seana Carson, Senior Vice President of Legal, will be appointed General Counsel of Bausch Health, effective as of the IPO Closing Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/885590/000088559021000047/0000885590-21-000047-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"General Counsel"}],"fact_type":"executive_change"},{"claim_id":"70a22cfe09","claim":"Joseph Gordon departed as other_named_officer at Bausch Health Companies Inc..","evidence_excerpt":"Joseph Gordon will also transfer with Bausch + Lomb, effective as of the IPO Closing Date, where he will lead Bausch + Lomb’s global consumer, vision care and surgical businesses as well as the EMEA ophthalmology pharmaceutical business.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/885590/000088559021000047/0000885590-21-000047-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"will transfer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}